Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

September 15, 2023 0:57 (London Time)

Beam Therapeutics

Youtube Subscribe

...

Sector: Biotechnology
Ticker: BEAM
Sentiment: 0.836
MarketCap: 1,982,363,510.0
High: 25.46 Low: 24.88

Open: 25.17 Close: 25.14 Change: -0.03

Stop waiting time to find out about Beam Therapeutics: Our AI summarizes all info about it.

Are looking for the most relevant information about Beam Therapeutics? Investor spend a lot of time searching for information to make investment decisions in Beam Therapeutics. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Beam Therapeutics are: Beam, Therapeutics, BEAM, share, last, Inc, Wall, and the most common words in the summary are: beam, therapeutic, stock, inc, buy, price, market, . One of the sentences in the summary was: Beam Therapies trades on the NASDAQ under the ticker symbol BEAM.. …

Concept Map

...

Semantic Network

...

Stock Summary

Beam Therapeutics generated $20.12 million in revenue for the quarter. Beam Therapies generated $21.5 billion in revenue in the first quarter..

Today's Summary

Beam Therapeutics (BEAM) reported earnings of -$1.08 per share, beating the Zacks Consensus Estimate of $-1.38 per share. Beam Therapies trades on the NASDAQ under the ticker symbol BEAM.

Today's News

Beam Therapeutics Inc. (NASDAQ:BEAM) is heavily dominated by institutional owners (Simply Wall St.) The Top 7 Growth Stocks in Biotech are 15 Most Shorted Stocks Right Now on Wall Street. Beam Therapeutics (BEAM) reported earnings of -$1.08 per share, beating the Zacks Consensus Estimate of $-1.38 per share. For their last quarter, Beam Therapedutics (Beam) reported. Their last quarter. For more information, visit Charles Schwab & Co. Beam Therapeutics Inc. (BEAM) announced that in August, the first patient was treated with BEAM-201, a quadruplex-edited allogeneic cell therapy. The first patient has been treated with the quadruple-edited ALLogeneic allogeneic allogeneics. The average price target includes all analyst analysis. Beam Therapeutics stock last closed at $25.03 , down 4.39% from the previous day, and has decreased 53.07% in one year. Beam Theraputics stock is currently +10.26% from its 52-week low. Beam Therapeutics trades on the NASDAQ under the ticker symbol BEAM. Beam Therapies trades on a market capitalization of $1.98B today (as of Sep 13, 2023) Beam Therapesur has 79,199,501 outstanding shares.

Stock Profile

" Russell Investments Group Ltd. increases stake in Beam Therapeutics; analysts provide mixed ratings and projections - best stocks. Beam Therapies generated $20.12 million in revenue for the quarter. Beam Therapeutics Inc. (US) job application for vp, business development at beam therapeutics. (NASDAQ:BEAM) Job Application for VP, Business Development at Beam Theraputics apply for this job. Beam Therapedutics has an analyst consensus of Moderate Buy, with a price target consensus of $49. Beam Therapeuticss stock price per share is $23.50 today (as of Aug 23, 2023) Beam Therapedutics stock market cap is $1.86B. If you had invested in Beam Theraputics stock at $18.75 your return over the last 3 years would have been 25.33%."

Keywords

How much time have you spent trying to decide whether investing in Beam Therapeutics? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Beam Therapeutics are: Beam, Therapeutics, BEAM, share, last, Inc, Wall, and the most common words in the summary are: beam, therapeutic, stock, inc, buy, price, market, . One of the sentences in the summary was: Beam Therapies trades on the NASDAQ under the ticker symbol BEAM.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #beam #therapeutic #stock #inc #buy #price #market.

Read more →

Related Results

...
November 30, 2023 0:19 (London Time)

Beam Therapeutics

Beam Therapeutics (BEAM) has 13.826M shares short, which is 21.51% of float and 8.12 times average daily trading volume. The company is laying off a…
Sector: Biotechnology
Ticker: BEAM
Sentiment: 0.7346
MarketCap: 2,426,375,776.0
High: 30.21 Low: 28.42

Open: 30.14 Close: 28.59 Change: -1.55

Read more →
...
September 15, 2023 0:57 (London Time)

Beam Therapeutics

Beam Therapeutics (BEAM) reported earnings of -$1.08 per share, beating the Zacks Consensus Estimate of $-1.38 per share. Beam Therapies trades on t…
Sector: Biotechnology
Ticker: BEAM
Sentiment: 0.836
MarketCap: 1,982,363,510.0
High: 25.46 Low: 24.88

Open: 25.17 Close: 25.14 Change: -0.03

Read more →
...
October 23, 2023 0:39 (London Time)

Beam Therapeutics

Beam Therapeutics, a Cambridge biotech developing medicines that rely on gene editing, said Thursday that it will lay off about 100 employees, 20 pe…
Sector: Biotechnology
Ticker: BEAM
Sentiment: 0.8947
MarketCap: 1,401,039,172.0
High: 18.34 Low: 16.95

Open: 17.76 Close: 17.69 Change: -0.07

Read more →
...
August 24, 2023 18:36 (London Time)

Beam Therapeutics

Beam Therapeutics generated $20.12 million in revenue for the quarter. Russell Investments Group Ltd. increases stake.
Sector: Biotechnology
Ticker: BEAM
Sentiment: 0.7506
MarketCap: 1,861,188,273.0
High: 23.46 Low: 22.7

Open: 23.46 Close: 23.19 Change: -0.27

Read more →